Targeting epigenetic modification | Drugs | Signalling pathway in colorectal | Ref |
---|---|---|---|
DNMTis | Disulfiram | Blocking the enzyme acetaldehyde dehydrogenase, targeting drug efflux pumps, induction of production of ROSs, activating the JNK and p38 MAPK signalling pathways, inhibition of NFκB and the proteasome activity | [193] |
Zebularine | Downregulation of GRP78 and p62 and upregulates a pro-apoptotic CHOP | [74] | |
Decitabine | PD-1 blockade | [194] | |
Azacitidine | At low doses, azacytidine targets CRC-initiating cells by inducing viral mimicry via the MDA5/MAVS/IRF7 pathway | [72] | |
Zebularine | Induces p53-dependent ER stress and autophagy. Increases the expression level of let-7b, which functions as tumour suppressor microRNA | [195] | |
HDACIs | Sulforaphane | Blocks Wnt/β-catenin signalling | [196] |
Vorinostat | Autophagy modulation | [197] | |
Resminostat | Amplification of AKT signalling | [198] | |
Belinostat | Induction of apoptosis | [199] | |
Panobinostat | Arresting the G1, G2/M cell cycle, activation of tumour suppressor gene death-associated protein kinase (DAPK), induction of autophagy, apoptosis and cell death |